Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Metformin, an oral insulin-sensitizing drug, is actively transported into cells by organic cation transporters (OCT) 1, 2, and 3 (encoded by SLC22A1, SLC22A2, or SLC22A3), which are tissue specifically expressed at significant levels in various organs such as liver, muscle, and kidney. Because metfo...
Main Authors: | Anne T Nies, Ute Hofmann, Claudia Resch, Elke Schaeffeler, Maria Rius, Matthias Schwab |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21779389/?tool=EBI |
Similar Items
-
Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.
by: Kristina Hacker, et al.
Published: (2015-01-01) -
Evaluation of Vitamin B12 Monitoring in Patients on Concomitant Metformin and Proton Pump Inhibitors
by: Logan Chappell, et al.
Published: (2020-10-01) -
OCT1-Mediated Metformin Uptake Regulates Pancreatic Stellate Cell Activity
by: Chunhua Wu, et al.
Published: (2018-06-01) -
Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters
by: Anne T. Nies, et al.
Published: (2021-03-01) -
Pharmacokinetic Interaction between Metformin and Verapamil in Rats: Inhibition of the OCT2-Mediated Renal Excretion of Metformin by Verapamil
by: Seung Yon Han, et al.
Published: (2020-05-01)